WVE Q1 2022 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

-$26M-1469.7% margin

Operating Income

-$38M-2176.8% margin

Net Income

-$38M-2160.8% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

-0.8%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$167M

Total Liabilities

$160M

Stockholders' Equity

$8M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	-$26M	$0	—
Operating Income	-$38M	-$43M	+12.4%
Net Income	-$38M	-$42M	+11.0%